186
Participants
Start Date
February 27, 2018
Primary Completion Date
September 30, 2024
Study Completion Date
September 30, 2024
ladiratuzumab vedotin
Given into the vein (IV; intravenously)
Pembrolizumab
IV infusion every 3 weeks
Weill Cornell Medicine, New York
CHA Bundang Medical Center, Seongnam
Complejo Hospitalario Universitario La Coruna, A Coruña
University of Pittsburgh Medical Center (UPMC)/Hillman Cancer Center, Pittsburgh
Helen F. Graham Cancer Center / Christiana Care Health Systems, Newark
University of Maryland, Baltimore
University of Virginia, Charlottesville
Complejo Hospitalario de Jaen, Jaén
MD Anderson Cancer Center - Madrid, Madrid
Hospital Ruber Internacional, Madrid
Hospital Universitario 12 de Octubre, Madrid
HM Centro Integral Oncologico Clara Campal, Madrid
Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón
Piedmont Cancer Institute, Atlanta
Winship Cancer Institute / Emory University School of Medicine, Atlanta
AdventHealth Cancer Institute, Orlando
Miami Cancer Institute at Baptist Health, Inc., Miami
H. Lee Moffitt Cancer Center and Research Institute, Tampa
University of Alabama at Birmingham, Birmingham
Kliniken Essen-Mitte - Evang. Huyssens-Stiftung, Essen
Marien Hospital Bottrop, Bottrop
Pusan National University Hospital, Busan
Gynakologisches Zentrum Bonn Friedensplatz, Bonn
Allina Health Cancer Institute, Minneapolis
Cardinal Bernardin Cancer Center / Loyola University Medical Center, Maywood
Ingalls Cancer Care / Ingalls Memorial Hospital, Harvey
Saint Luke's Cancer Institute LLC, Kansas City
Texas Oncology - DFW, Dallas
Texas Oncology - Houston Memorial City, Houston
Texas Oncology - San Antonio Medical Center Northeast, San Antonio
Rocky Mountain Cancer Centers - Aurora, Aurora
Klinikum der Universitat Munchen, München
Rotkreuzklinikum Munich, Munich
Klinikum Rechts der Isar der Technischen Universitaet Muenchen, München
New Mexico Cancer Center, Albuquerque
Cedars Sinai Medical Center / Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Universitatsklinikum Erlangen, Erlangen
Chao Family Comprehensive Cancer Center University of California Irvine, Orange
University of California Irvine - Newport, Orange
The Whittingham Cancer Center / Norwalk Hospital, Norwalk
Summit Medical Group, Florham Park
Fred Hutchinson Cancer Center / Seattle Cancer Care Alliance / University of Washington, Seattle
Stadtisches Klinikum Dessau, Dessau
Korea Cancer Center Hospital, Seoul
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Samsung Medical Center, Seoul
Hospital del Mar, Barcelona
Hospital Universitari Vall d'Hebron, Barcelona
L'Institut Catala d'Oncologia, L'Hospitalet de Llobregat
Merck Sharp & Dohme LLC
INDUSTRY
Seagen Inc.
INDUSTRY